Best Practices, LLC Research Highlights Critical Role of Medical Marketing in New Product Launch Success

CHAPEL HILL, N.C., Sept. 10 /PRNewswire/ -- New Product Planning (NPP) groups play a vital role in many of the new product development activities that set the stage for a successful launch. One of the areas of growing importance for NPP groups is medical marketing activities such as ad boards, and thought leader identification and education. Leading organizations understand that investing in educating the medical community about a new product creates a foundation for a strong launch. Effective medical marketing-driven strategies are key to successfully differentiating new products and ensuring a strong product launch.

The Best Practices, LLC benchmarking report New Product Planning: Role and Activities for Medical Marketing provides a detailed examination of the timing and value of Medical Marketing activities. In addition, this study presents an overview of the NPP role in the new product development process and the timing of key NPP activities during the development cycle. Executives and managers can use this study to inform and shape their thinking around the challenges of Medical Marketing activities for new product development.

Key topics in this 50-slide report are:

• The current state of New Product Planning in pharma
• Overview of New Product Planning activities and timing during development process
• Review the main Medical Marketing activities carried out during the development process and drill down on their timing, intended outcomes, and value for the organization

To download a complimentary study excerpt, go to: http://www3.best-in-class.com/rr1021.htm.

Best Practices, LLC used both field surveys and interviews to complete this study. In all, 27 New Product Planning leaders at 25 pharma companies across the globe contributed data. In-depth interviews were conducted with leaders from 13 of the participating companies. The research report reflects the current state of New Product Planning efforts at best-in-class organizations such as Abbott, Astellas, Bayer, Daiichi Sankyo, Eli Lilly, Merck, Novartis, sanofi-aventis, Wyeth and others.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC serves 48 of the world's 50 top pharmaceutical companies.  For 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. 

SOURCE Best Practices, LLC